Resonance Health Ltd (AU:RHT) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Resonance Health Ltd has reported strong financial performance with customer receipts reaching $3.2 million for the quarter, marking a 186% increase compared to the previous fiscal year. The company continues to expand its operations, particularly through its TrialsWest clinical trial site services, which have surpassed expectations and are poised for further growth with new sites planned. Additionally, their Software-as-a-Medical Device business is gaining traction globally, contributing to a solid cash balance of $5.78 million.
For further insights into AU:RHT stock, check out TipRanks’ Stock Analysis page.